Related Experiment Video
Updated: Aug 17, 2026

Mouse Naïve CD4+ T Cell Isolation and In vitro Differentiation into T Cell Subsets
Published on: April 16, 2015
T cells can be cytotoxic without making interleukin 2: a model of separate pathways of induction
Abstract:
The thoracic duct lymphocytes from rats previously injected with ultraviolet-light-irradiated allogeneic lymphocytes were grown for 4 days with alloantigen, with or without Con A-induced lymphokine factors, and then for 3 days with the lymphokines alone. They were then tested for their cytoxicity and for their capacity to make interleukin 2 (IL-2) in response to antigen. The results show that T helper cells specific for both class I and class II antigens of the major histocompatibility complex were removed from the circulation by the injection of ultraviolet-irradiated alloantigen. However, precursors of cytotoxic cells remained and appeared to lose their OX-19 markers during activation. We have interpreted the results by using a speculative model that involves separate pathways of induction to cytotoxicity and IL-2 synthesis. We propose that the OX-19 marker is associated with the interleukin 1 receptor and that the latter is required for the IL-2 production pathway but not for activation to cytotoxicity.
Related Concept Videos
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Tumor Immunotherapy

